Natural Killer Cell Cytokine Response to M. bovis BCG Is Associated with Inhibited Proliferation, Increased Apoptosis and Ultimate Depletion of NKp44+CD56bright Cells

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Portevin, Damien ^a,b   Young, Douglas ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; INTERLEUKIN 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL FATE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MYCOBACTERIUM BOVIS; NATURAL KILLER CELL; PROTEIN EXPRESSION; T CELL DEPLETION;

ANTIGENS, CD56; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; MYCOBACTERIUM BOVIS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

EID: 84880275924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068864     Document Type: Article

References (35)

1. Hayashi D, Takii T, Fujiwara N, Fujita Y, Yano I, et al. (2009) Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains. FEMS Immunol Med Microbiol 56(2):: 116-128. doi:10.1111/j.1574-695X.2009.00559.x. PubMed: 19453755.
2. van den Biggelaar AHJ, Prescott SL, Roponen M, Nadal-Sims MA, Devitt CJ, et al. (2009) Neonatal innate cytokine responses to BCG controlling T-cell development vary between populations. J Allergy Clin Immunol 124(3):: 544-550, 550.e1-2. doi:10.1016/j.jaci.2009.03.040. PubMed: 19500827.
3. Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70(2):: 672-678. doi:10.1128/IAI.70.2.672-678.2002. PubMed: 11796598.
4. World Health Organization (2011) Weekly epidemiological record. Global routine vaccination coverage, 2010. Available: http://www.who.int/wer/2011/wer8646.pdf.
5. Mmajla, Manzanilla-García HA (2009) Bacillus Calmette-Guérin immunotherapy in the treatment of superficial bladder cancer. Rev Mex Urol (6): 307-313.
6. Uyl-de Groot CA, Vermorken JB, Hanna MG, Verboom P, Groot MT, et al. (2005) Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine 23(17-18):: 2379-2387. doi:10.1016/j.vaccine.2005.01.015. PubMed: 15755632.
7. Pereira LIA, Dorta ML, Pereira AJCS, Bastos RP, Oliveira MAP, et al. (2009) Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens. Am J Trop Med Hyg 81(3):: 378-383. PubMed: 19706899.
8. Alexandroff AB, Nicholson S, Patel PM, Jackson AM, (2010) Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer. J Immunother 2(4):: 551-560. doi:10.2217/imt.10.32. PubMed: 20636008.
9. Jackson AM, Alexandroff AB, Kelly RW, Skibinska A, Esuvaranathan K, et al. (1995) Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol 99(3):: 369-375. PubMed: 7882559.
10. Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG, (2005) Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb) 85(3):: 159-176. doi:10.1016/j.tube.2004.10.001.
11. Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, et al. (2001) NK cells are essential for effective BCG immunotherapy. Int J Cancer 92(5):: 697-702. doi:10.1002/1097-0215(20010601)92:5. PubMed: 11340575.
12. Watkins MLV, Semple PL, Abel B, Hanekom WA, Kaplan G, et al. (2008) Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clin Vaccine Immunol 15(11):: 1666-1673. doi:10.1128/CVI.00202-08. PubMed: 18815231.
13. Portevin D, Via LE, Eum S, Young D, (2012) Natural killer cells are recruited during pulmonary tuberculosis and their ex vivo responses to mycobacteria vary between healthy human donors in association with KIR haplotype. Cell Microbiol, 14: 1734-44. PubMed: 22788220.
14. Marcenaro E, Ferranti B, Falco M, Moretta L, Moretta A, (2008) Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol 20(9):: 1155-1167. doi:10.1093/intimm/dxn073. PubMed: 18596023.
15. Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL, et al. (2008) Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun 76(4):: 1719-1727. doi:10.1128/IAI.00870-07. PubMed: 18212080.
16. Poli A, Michel T, Thérésine M, Andrès E, Hentges F, et al. (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126(4):: 458-465. doi:10.1111/j.1365-2567.2008.03027.x. PubMed: 19278419.
17. Grégoire C, Chasson L, Luci C, Tomasello E, Geissmann F, et al. (2007) The trafficking of natural killer cells. Immunol Rev 220: 169-182. doi:10.1111/j.1600-065X.2007.00563.x. PubMed: 17979846.
18. Pokkali S, Das SD, Selvaraj A, (2009) Differential upregulation of chemokine receptors on CD56 NK cells and their transmigration to the site of infection in tuberculous pleurisy. FEMS Immunol Med Microbiol 55(3):: 352-360. doi:10.1111/j.1574-695X.2008.00520.x. PubMed: 19159432.
19. Brandau S, Böhle A, (2001) Activation of natural killer cells by Bacillus Calmette-Guérin. Eur Urol 39(5):: 518-524. doi:10.1159/000052497. PubMed: 11464031.
20. Evans JH, Horowitz A, Mehrabi M, Wise EL, Pease JE, et al. (2011) A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur J Immunol 41(7):: 1924-1933. doi:10.1002/eji.201041180. PubMed: 21491418.
21. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, et al. (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189(5):: 787-796. doi:10.1084/jem.189.5.787. PubMed: 10049942.
22. Portevin D, Poupot M, Rolland O, Turrin CO, Fournié JJ, et al. (2009) Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy. J Transl Med 7: 82. doi:10.1186/1479-5876-7-82. PubMed: 19778420.
23. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):: 633-640. doi:10.1016/S1471-4906(01)02060-9. PubMed: 11698225.
24. Schierloh P, Yokobori N, Geffner L, Balboa L, Romero MM, et al. (2009) NK cells from tuberculous pleurisy express high ICAM-1 levels and exert stimulatory effect on local T cells. Eur J Immunol 39(9):: 2450-2458. doi:10.1002/eji.200939515. PubMed: 19714575.
25. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, et al. (2006) NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J Immunol 177(10):: 7086-7093. PubMed: 17082625.
26. Fauriat C, Long EO, Ljunggren HG, Bryceson YT, (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115(11):: 2167-2176. doi:10.1182/blood-2009-08-238469. PubMed: 19965656.
27. Reefman E, Kay JG, Wood SM, Offenhäuser C, Brown DL, et al. (2010) Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells. J Immunol 184(9):: 4852-4862. doi:10.4049/jimmunol.0803954. PubMed: 20368273.
28. Esin S, Batoni G, Pardini M, Favilli F, Bottai D, et al. (2004) Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Immunology 112(1):: 143-152. doi:10.1111/j.1365-2567.2004.01858.x. PubMed: 15096193.
29. Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, et al. (2004) Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104(6):: 1778-1783. doi:10.1182/blood-2003-08-2820. PubMed: 15166032.
30. Robertson MJ, Caligiuri MA, Manley TJ, Levine H, Ritz J, (1990) Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J Immunol 145(10):: 3194-3201. PubMed: 1700001.
31. Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, et al. (1993) Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest 91(1):: 123-132. doi:10.1172/JCI116161. PubMed: 7678599.
32. Batoni G, Esin S, Favilli F, Pardini M, Bottai D, et al. (2005) Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scand J Immunol 62(6):: 498-506. doi:10.1111/j.1365-3083.2005.01692.x. PubMed: 16316416.
33. Ross ME, Caligiuri MA, (1997) Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 89(3):: 910-918. PubMed: 9028322.
34. Sun JC, Beilke JN, Lanier LL, (2009) Adaptive immune features of natural killer cells. Nature 457(7229):: 557-561. doi:10.1038/nature07665. PubMed: 19136945.
35. Schierloh P, Yokobori N, Alemán M, Musella RM, Beigier-Bompadre M, et al. (2005) Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy. J Immunol 175(10):: 6852-6860. PubMed: 16272343.